ROTHSCHILD & CO ASSET MANAGEMENT US INC. - AMICUS THERAPEUTICS INC ownership

AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 217 filers reported holding AMICUS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.30 and the average weighting 0.3%.

Quarter-by-quarter ownership
ROTHSCHILD & CO ASSET MANAGEMENT US INC. ownership history of AMICUS THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$8,134,470
+9.1%
666,214
-6.7%
0.12%
-2.4%
Q3 2022$7,454,000
-20.5%
713,946
-18.2%
0.13%
-11.8%
Q2 2022$9,372,000
+8.2%
872,600
-4.6%
0.14%
+29.7%
Q1 2022$8,661,000
-38.2%
914,615
-24.7%
0.11%
-32.7%
Q4 2021$14,023,000
+16.4%
1,214,117
-3.7%
0.16%
+10.7%
Q3 2021$12,044,000
-11.3%
1,261,163
-10.4%
0.15%
-7.5%
Q2 2021$13,572,000
+19.9%
1,407,931
+22.9%
0.16%
+15.0%
Q1 2021$11,318,000
-66.9%
1,145,594
-22.7%
0.14%
-68.2%
Q4 2020$34,230,000
+37.4%
1,482,467
-15.9%
0.44%
-2.0%
Q3 2020$24,904,000
-5.3%
1,763,730
+1.1%
0.45%
+16.0%
Q2 2020$26,306,000
+40.0%
1,744,457
-14.2%
0.39%
+32.1%
Q1 2020$18,786,000
-12.4%
2,033,120
-7.6%
0.29%
+31.4%
Q4 2019$21,437,000
+76.0%
2,200,907
+45.0%
0.22%
+68.9%
Q3 2019$12,177,000
-36.4%
1,518,340
-1.0%
0.13%
-35.3%
Q2 2019$19,150,000
-5.6%
1,534,423
+2.9%
0.20%
-6.0%
Q1 2019$20,277,000
+39.1%
1,490,940
-2.0%
0.22%
+23.3%
Q4 2018$14,574,000
-19.6%
1,521,339
+1.4%
0.18%
-5.4%
Q3 2018$18,131,000
+392.8%
1,499,686
+536.8%
0.19%
+365.0%
Q2 2018$3,679,000
+154.4%
235,513
+145.0%
0.04%
+150.0%
Q1 2018$1,446,000
+8.6%
96,131
+3.9%
0.02%
+14.3%
Q4 2017$1,331,00092,5090.01%
Other shareholders
AMICUS THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Palo Alto Investors LP 10,114,043$116,817,0007.46%
Parametrica Management Ltd 597,279$6,899,0006.86%
Redmile Group, LLC 22,716,086$262,371,0005.96%
Perceptive Advisors 53,118,886$613,524,0004.73%
Asymmetry Capital Management, L.P. 716,709$8,278,0004.39%
CM Management, LLC 450,000$5,198,0003.93%
Avoro Capital Advisors LLC 18,500,000$213,675,0003.64%
Kynam Capital Management, LP 573,699$6,626,0003.54%
SECTORAL ASSET MANAGEMENT INC 1,242,882$14,355,0002.16%
Ghost Tree Capital, LLC 500,000$5,775,0002.07%
View complete list of AMICUS THERAPEUTICS INC shareholders